These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 21763211

  • 21. Time course of depression-symptom improvement during treatment with duloxetine.
    Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ.
    Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
    [Abstract] [Full Text] [Related]

  • 22. A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain.
    Sullivan MD, Bentley S, Fan MY, Gardner G.
    J Pain; 2009 Feb; 10(2):208-13. PubMed ID: 18976962
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.
    Depress Anxiety; 2008 Feb; 25(7):E1-11. PubMed ID: 17587217
    [Abstract] [Full Text] [Related]

  • 24. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ, Myers RR.
    Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U.
    Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417
    [Abstract] [Full Text] [Related]

  • 26. The effect of duloxetine treatment on cognition in patients with fibromyalgia.
    Mohs R, Mease P, Arnold LM, Wang F, Ahl J, Gaynor PJ, Wohlreich MM.
    Psychosom Med; 2012 Jan; 74(6):628-34. PubMed ID: 22753629
    [Abstract] [Full Text] [Related]

  • 27. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
    Skljarevski V, Zhang S, Chappell AS, Walker DJ, Murray I, Backonja M.
    Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
    [Abstract] [Full Text] [Related]

  • 28. Duloxetine: in patients with fibromyalgia.
    Curran MP.
    Drugs; 2009 Jun 18; 69(9):1217-27. PubMed ID: 19537838
    [Abstract] [Full Text] [Related]

  • 29. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
    Gaynor P, McCarberg B, Zheng W, Shoemaker S, Duenas H.
    Int J Clin Pract; 2011 Mar 18; 65(3):341-9. PubMed ID: 21314871
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK, Mallinckrodt CH, Detke MJ, Watkin JG, Tollefson GD.
    J Psychiatr Res; 2005 Mar 18; 39(2):161-72. PubMed ID: 15589564
    [Abstract] [Full Text] [Related]

  • 32. History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia.
    Pae CU, Masand PS, Marks DM, Krulewicz S, Peindl K, Mannelli P, Patkar AA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug 31; 33(6):996-1002. PubMed ID: 19433129
    [Abstract] [Full Text] [Related]

  • 33. Nabilone for the treatment of pain in fibromyalgia.
    Skrabek RQ, Galimova L, Ethans K, Perry D.
    J Pain; 2008 Feb 31; 9(2):164-73. PubMed ID: 17974490
    [Abstract] [Full Text] [Related]

  • 34. Relationships among pain, depressed mood, and global status in fibromyalgia patients: post hoc analyses of a randomized, placebo-controlled trial of milnacipran.
    Arnold LM, Palmer RH, Gendreau RM, Chen W.
    Psychosomatics; 2012 Feb 31; 53(4):371-9. PubMed ID: 22677218
    [Abstract] [Full Text] [Related]

  • 35. A meta-analysis of pain response in the treatment of fibromyalgia.
    Roskell NS, Beard SM, Zhao Y, Le TK.
    Pain Pract; 2011 Feb 31; 11(6):516-27. PubMed ID: 21199320
    [Abstract] [Full Text] [Related]

  • 36. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun 31; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.
    BMC Psychiatry; 2005 Jan 04; 5():1. PubMed ID: 15631624
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec 04; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.